AbaÑo, Baby Girl 2 .
HRN: 24-60-65 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/27/2024
AMPICILLIN 250MG (VIAL)
02/27/2024
03/05/2024
IV
50mg
Q12
PSNB
Waiting Final Action
Indication: Prophylaxis Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes